Gonadorelin, also known as gonadotropin-releasing hormone (GnRH), is a synthetic decapeptide designed to replicate the structure and function of the endogenous hormone. This oligopeptide consists of ten amino acids, including pyroglutamyl, histidyl, tryptophyl, and arginyl residues. Synthesized in the hypothalamus, gonadorelin binds to LHRH receptors on pituitary gonadotropic cells, promoting the release of FSH and LH. Its mechanism supports the synthesis of gonadotropins, essential for reproductive health. When administered continuously, gonadorelin desensitizes gonadotropic cells, reducing hormone secretion. This unique property makes it valuable for treating hypothalamic amenorrhea and assessing pituitary function, highlighting its significance in medical applications.
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Gonadorelin by Ultima Pharmaceuticals, consult with your doctor or healthcare professional.
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem